Xwell (XWEL) Net Income towards Common Stockholders (2010 - 2026)
Xwell's (XWEL) quarterly Net Income towards Common Stockholders came in at -$11.2 million in Q1 2026, down 111.46% year-on-year from $97.5 million in Q1 2025, and up 39.36% quarter-over-quarter from -$18.4 million in Q4 2025.
Xwell (XWEL) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Xwell has disclosed Net Income towards Common Stockholders across 15 years of filings, most recently posting -$11.2 million for Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at -$11.2 million, down 111.46% year-over-year; the trailing twelve-month figure through Mar 2026 was -$34.1 million (down 73.87% YoY), and the FY2025 annual result was -$28.2 million, down 67.53% from the prior year.
- Net Income towards Common Stockholders came in at -$11.2 million for Q1 2026 at Xwell, up from -$18.4 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$1.5 million in Q3 2025 to a low of -$18.4 million in Q4 2025.
- The 5-year median for Net Income towards Common Stockholders is -$5.5 million (2023), against an average of -$6.8 million.
- Across the five-year window, Net Income towards Common Stockholders sank 876.74% in 2022 and jumped 68.99% in 2025, its largest moves.
- Xwell's Net Income towards Common Stockholders stood at -$14.3 million in 2022, then jumped by 65.68% to -$4.9 million in 2023, then slumped by 55.16% to -$7.6 million in 2024, then slumped by 142.7% to -$18.4 million in 2025, then surged by 39.36% to -$11.2 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$11.2 million (Q1 2026), -$18.4 million (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 141.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -85.11 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Xwell | 8.65 Mn | 1.54 Mn | 2.35 Mn | -11.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.18 Mn |
| Dec 31, 2025 | -18.43 Mn |
| Sep 30, 2025 | -1.47 Mn |
| Jun 30, 2025 | -3.04 Mn |
| Mar 31, 2025 | -5.29 Mn |
| Dec 31, 2024 | -7.60 Mn |
| Sep 30, 2024 | -4.75 Mn |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -2.51 Mn |
| Dec 31, 2023 | -4.90 Mn |
| Sep 30, 2023 | -11.53 Mn |
| Jun 30, 2023 | -5.73 Mn |
| Mar 31, 2023 | -5.51 Mn |
| Dec 31, 2022 | -14.26 Mn |
| Sep 30, 2022 | -7.18 Mn |
| Jun 30, 2022 | -7.93 Mn |
| Mar 31, 2022 | -2.76 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 5.60 Mn |
| Jun 30, 2021 | -4.73 Mn |